Science ❯ Biotechnology ❯ Drug Research

Clinical Trials

Therapeutics Phase 3 Trials Pharmacokinetics Phase 1 Trials Market Approval Processes FDA Approval Late-Stage Testing Market Predictions Regulatory Approval Neuromuscular Diseases Weight Loss Medications

New Oral Drug Nearly Doubles Survival for Treated Metastatic Pancreatic Cancer

Targeting mutant KRAS through cyclophilin A, the pill has been made available under an FDA expanded access pathway pending formal review.

Eli Lilly to Acquire Ventyx Biosciences for $1.2 Billion in Bet on Oral NLRP3 Drugs

European Commission Authorizes Gobivaz, First Simponi Biosimilar, Across the EEA